跳至主要内容
临床试验/ACTRN12626000927325
ACTRN12626000927325招募中不适用

A prospective observational study investigating the association between Genea Natural Killer (NK) Cell Activity Test results and reproductive outcomes in patients undergoing assisted reproductive treatment.

Professor Gavin Sacks - Flow fertility with Genea0 个研究点目标入组 1,200 人开始时间: 2026年7月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
No limit 至 40 Years(—)
性别
Female

入选标准

  • Women below 40 years.
  • Any fertility diagnosis requiring an embryo transfer within 6 months of the blood test
  • Consent to being blinded to the result for the first transfer and NOT taking any
  • immune therapy (clexane, prednisolone, dexamethasone, intralipid, PRP, LIT, anti
  • TNF) for the first transfer.
  • Undergoing IVF/ICSI for fresh transfer, or frozen embryo transfer.
  • Can include PGT cases.
  • The study is open to first time patients as well as those with previous failures or
  • miscarriages.

排除标准

  • Women aged >40 years.
  • Taking any immune therapy with 2 months of the test.
  • Taking any immune therapy for other systemic disease.
  • Unwilling to proceed with first embryo transfer without immune therapy.
  • Egg freezing only.
  • Patients must not already be pregnant

研究者

发起方
Professor Gavin Sacks - Flow fertility with Genea

相似试验